Literature DB >> 25563585

Mitochondrial induction as a potential radio-sensitizer in lung cancer cells - a short report.

Ronen Shavit1, Maya Ilouze, Tali Feinberg, Yaacov Richard Lawrence, Yossi Tzur, Nir Peled.   

Abstract

INTRODUCTION: Lung cancer is the leading cause of cancer death. Radiation therapy plays a key role in its treatment. Ionizing radiation induces cell death through chromosomal aberrations, which trigger mitotic catastrophe and apoptosis. However, many lung cancer patients show resistance to radiation. Dichloroacetate (DCA) is a small molecule that can promote mitochondrial activation by increasing the influx of pyruvate. Here, we tested whether DCA may increase the sensitivity of non-small cell lung cancer (NSCLC) cells to radiation through this mechanism.
METHODS: Two representative NSCLC cell lines (A549 and H1299) were tested for their sensitivity to radiation with and without pre-exposure to DCA. The treatment efficacy was evaluated using a clonogenic survival assay. An extracellular flux analyzer was used to assess the effect of DCA on cellular oxygen consumption as a surrogate marker for mitochondrial activity.
RESULTS: We found that DCA increases the oxygen consumption rate in both A549 and H1299 cells by 60% (p = 0.0037) and 20% (p = 0.0039), respectively. Pre-exposure to DCA one hour before radiation increased the cytotoxic death rate 4-fold in A549 cells (55 to 13%, p = 0.004) and 2-fold in H1299 cells (35 to 17%, p = 0.28) respectively, compared to radiation alone.
CONCLUSION: Mitochondrial induction by DCA may serve as a radio-sensitizer in non-small cell lung cancer.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25563585     DOI: 10.1007/s13402-014-0212-6

Source DB:  PubMed          Journal:  Cell Oncol (Dordr)        ISSN: 2211-3428            Impact factor:   6.730


  29 in total

1.  A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth.

Authors:  Sébastien Bonnet; Stephen L Archer; Joan Allalunis-Turner; Alois Haromy; Christian Beaulieu; Richard Thompson; Christopher T Lee; Gary D Lopaschuk; Lakshmi Puttagunta; Sandra Bonnet; Gwyneth Harry; Kyoko Hashimoto; Christopher J Porter; Miguel A Andrade; Bernard Thebaud; Evangelos D Michelakis
Journal:  Cancer Cell       Date:  2007-01       Impact factor: 31.743

Review 2.  Death through a tragedy: mitotic catastrophe.

Authors:  H Vakifahmetoglu; M Olsson; B Zhivotovsky
Journal:  Cell Death Differ       Date:  2008-04-11       Impact factor: 15.828

Review 3.  Cancer treatment and survivorship statistics, 2012.

Authors:  Rebecca Siegel; Carol DeSantis; Katherine Virgo; Kevin Stein; Angela Mariotto; Tenbroeck Smith; Dexter Cooper; Ted Gansler; Catherine Lerro; Stacey Fedewa; Chunchieh Lin; Corinne Leach; Rachel Spillers Cannady; Hyunsoon Cho; Steve Scoppa; Mark Hachey; Rebecca Kirch; Ahmedin Jemal; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2012-06-14       Impact factor: 508.702

4.  An effective strategy for increasing the radiosensitivity of Human lung Cancer cells by blocking Nrf2-dependent antioxidant responses.

Authors:  Saelooom Lee; Min-Jin Lim; Mi-Hyoung Kim; Chi-Ho Yu; Yeon-Sook Yun; Jiyeon Ahn; Jie-Young Song
Journal:  Free Radic Biol Med       Date:  2012-06-07       Impact factor: 7.376

Review 5.  DNA repair targeting and radiotherapy: a focus on the therapeutic ratio.

Authors:  John Thoms; Robert G Bristow
Journal:  Semin Radiat Oncol       Date:  2010-10       Impact factor: 5.934

Review 6.  Regulation of cancer cell metabolism.

Authors:  Rob A Cairns; Isaac S Harris; Tak W Mak
Journal:  Nat Rev Cancer       Date:  2011-02       Impact factor: 60.716

7.  The role of radiation-induced apoptosis as a determinant of tumor responses to radiation therapy.

Authors:  B A Rupnow; S J Knox
Journal:  Apoptosis       Date:  1999-04       Impact factor: 4.677

8.  Dichloroacetate (DCA) sensitizes both wild-type and over expressing Bcl-2 prostate cancer cells in vitro to radiation.

Authors:  Wengang Cao; Saif Yacoub; Kathleen T Shiverick; Kazunori Namiki; Yoshihisa Sakai; Stacy Porvasnik; Cydney Urbanek; Charles J Rosser
Journal:  Prostate       Date:  2008-08-01       Impact factor: 4.104

9.  Ionizing radiation induces mitochondrial reactive oxygen species production accompanied by upregulation of mitochondrial electron transport chain function and mitochondrial content under control of the cell cycle checkpoint.

Authors:  Tohru Yamamori; Hironobu Yasui; Masayuki Yamazumi; Yusuke Wada; Yoshinari Nakamura; Hideo Nakamura; Osamu Inanami
Journal:  Free Radic Biol Med       Date:  2012-05-08       Impact factor: 7.376

Review 10.  Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer.

Authors:  E D Michelakis; L Webster; J R Mackey
Journal:  Br J Cancer       Date:  2008-09-02       Impact factor: 7.640

View more
  5 in total

1.  Giganteaside D induces ROS-mediated apoptosis in human hepatocellular carcinoma cells through the MAPK pathway.

Authors:  Junshan Liu; Xiduan Wei; Yafeng Wu; Yanni Wang; Yuwen Qiu; Junmin Shi; Hongling Zhou; Zibin Lu; Meng Shao; Linzhong Yu; Li Tong
Journal:  Cell Oncol (Dordr)       Date:  2016-03-25       Impact factor: 6.730

2.  Anti-tumor effect of emodin on gynecological cancer cells.

Authors:  Yaoxian Wang; Hui Yu; Jin Zhang; Xin Ge; Jing Gao; Yunyan Zhang; Ge Lou
Journal:  Cell Oncol (Dordr)       Date:  2015-07-11       Impact factor: 6.730

3.  MDMX is a prognostic factor for non-small cell lung cancer and regulates its sensitivity to cisplatin.

Authors:  Han Zhao; Yu-Zhuo Xie; Rui Xing; Ming Sun; Feng Chi; Yue-Can Zeng
Journal:  Cell Oncol (Dordr)       Date:  2017-05-31       Impact factor: 6.730

Review 4.  Hypoxia, metabolism, and the circadian clock: new links to overcome radiation resistance in high-grade gliomas.

Authors:  Han Shen; Kristina Cook; Harriet E Gee; Eric Hau
Journal:  J Exp Clin Cancer Res       Date:  2020-07-07

5.  Dichloroacetate Radiosensitizes Hypoxic Breast Cancer Cells.

Authors:  Sven de Mey; Inès Dufait; Heng Jiang; Cyril Corbet; Hui Wang; Melissa Van De Gucht; Lisa Kerkhove; Ka Lun Law; Hugo Vandenplas; Thierry Gevaert; Olivier Feron; Mark De Ridder
Journal:  Int J Mol Sci       Date:  2020-12-09       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.